Indeed, one study found that ERG overexpression in PCa from Pten-deficient mouse prostate mitigated responses to both AR-targeted therapy and combination therapy with a phosphatidylinositol 3-kinase (PI3K) inhibitor (BEZ3235), and this was associated with maintenance of AR target gene expression (19). Here, PIK3CA is linked to posterior cortical atrophy.